SARS-CoV-2 Omicron BQ.1.1 Variant Pseudovirus

• Background:

  SARS-CoV-2 Omicron Pseudovirus uses HIV pseudotyped with SARS-CoV-2 spike protein and firefly luciferase reporter. This pseudovirus effectively infects human ACE2 overexpressing cells and can be used to screen for inhibitors of Spike-ACE2 interaction, determine neutralizing antibody titers, and is a valuable tool for COVID-19 vaccine development as well.

• NCBI Gene ID:

  43740568

• Swiss Prot:

  P0DTC1

• Accession Number:

  QHD43416

• Type:

  Pseudovirus

• Source:

  HEK293 cells

• Field of Research:

  Infectious Disease, COVID-19

• Buffer:

  DMEM/10% FBS

• Shipping Conditions:

  Dry Ice

• Storage Conditions:

  The pseudovirus is stable in a liquid state at -70˚ for 12 months. Avoid repeated freeze-thaw cycles.

• Applications Notes:

  Click here to download6

• NCBI Official Name:

  Surface glycoprotein

• NCBI Organism:

  Severe acute respiratory syndrome coronavirus 2

• Other Product Names:

  Spike glycoprotein Receptor-binding domain, S glycoprotein, Spike protein, Omicron variant spike, Omicron variant pseudovirus, Omicron, pseudovirus reporter, reporter virus particle

• Tested Applications:

  Neutralization assay, Viral Infection

• Species:

  SARS-CoV-2 (COVID-19) Spike pseudovirus

• Protein ID:

  1791269090

• Physical Properties:

  Liquid